More ER-positive and in situ cancers and fewer ER-negative cancers are expected, which has implications for research priorities, researchers say.
Medscape Medical News …read more
More ER-positive and in situ cancers and fewer ER-negative cancers are expected, which has implications for research priorities, researchers say.
Medscape Medical News …read more